Clinical trial
LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs: A Randomized Controlled Trial of Injection at the Brachial Plexus
NCT03887650 is registered in ClinicalTrials.gov with Hartford Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs: A Randomized Controlled Trial of Injection at the Brachial Plexus
- Lead sponsor
- Hartford Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 11, 2019
- Completion date
- March 8, 2022
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteoarthritis of the shoulder, pain management, post-operative pain, total shoulder arthroplasty